期刊
FUTURE MEDICINAL CHEMISTRY
卷 8, 期 15, 页码 1841-1869出版社
FUTURE SCI LTD
DOI: 10.4155/fmc-2016-0056
关键词
dbCICA; FGFR-1; pharmacophore; QSAR; virtual search
资金
- Deanship of Scientific Research at the University of Jordan
Aim: FGFR-1 is an oncogenic kinase involved in several cancers. FGFR1-specific inhibitors have shown promising results against several human cancers prompting us to model this interesting target. Toward the end, we implemented elaborate ligand-based and structure-based computational workflows to explore the pharmacophoric requirements for potent FGFR-1 inhibitors. Results & methodology: Structure-based and ligand-based modeling applied on 59 diverse FGFR-1 inhibitors yielded novel pharmacophore and quantitative structure-activity relationship models that were used to scan the National Cancer Institute's structural database for novel leads. Four potent hits were captured, with the most active having IC50 of 426 nM. Identities and purities of active hits were established using nuclear magnetic resonance and mass spectroscopy. Conclusion: Elaborate ligand-based (pharmacophore/QSAR) and structure-based (docking-based comparative intermolecular contacts analysis) modeling provided deep understanding of ligand binding within FGFR-1 as evidenced by the virtually captured new potent leads.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据